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Summary
Heterochromatin protein-1 (HP1) plays an essential
role in both the assembly of higher-order chromatin
structure and epigenetic inheritance. The C-terminal
chromo shadow domain (CSD) of HP1 is responsible
for homodimerization and interaction with a number
of chromatin-associated nonhistone proteins, includ-
ing EMSY, which is a BRCA2-interacting protein that
has been implicated in the development of breast
and ovarian cancer. We have determined the crystal
structure of the HP1bCSD in complexwith the N-termi-
nal domain of EMSY at 1.8 A˚ resolution. Surprisingly,
the structure reveals that EMSY is bound by two HP1
CSD homodimers, and the binding sequences differ
from the consensus HP1 binding motif PXVXL. This
structural information expands our understanding of
HP1 binding specificity and provides insights into in-
teractions between HP1 homodimers that are likely
to be important for heterochromatin formation.
Introduction
Heterochromatin protein-1 (HP1) is a conserved chro-
matin-associated protein important for both the assem-
bly of higher-order chromatin structure and regulation of
gene transcription (Eissenberg and Elgin, 2000; Maison
and Almouzni, 2004). HP1 was first discovered in Dro-
sophila, and it plays essential roles in position effect var-
iegation, which is a phenomenon of epigenetic gene si-
lencing through heterochromatin formation (Eissenberg
et al., 1990; James et al., 1989; Wustmann et al., 1989).
HP1 achieves its silencing function by directly binding
to chromatin and spreading across the entire silenced
chromosomal region (Maison and Almouzni, 2004).
Similar mechanisms of epigenetic control of gene ex-
pression are employed in organisms from yeasts to hu-
mans and in diverse biological processes ranging from
mating-type switching to X chromosome inactivation
(Grewal and Elgin, 2002; Jaenisch and Bird, 2003; Nusi-
now and Panning, 2005; Rusche et al., 2003). HP1 and
localized heterochromatic foci have also been impli-
cated in cellular senescence and cancer development
(Narita et al., 2003; Nielsen et al., 2001).
In Drosophila and mammals, there are three HP1 ho-
mologs: HP1a, HP1b, and HP1g. The three proteins are
highly related, yet they are distributed in distinct chro-
mosomal regions. HP1a and HP1b are predominantly
associated with heterochromatin, while HP1g is mostly
euchromatic (Maison and Almouzni, 2004). All HP1 pro-
teins have a highly conserved chromo domain at the
N terminus and a well-conserved chromo shadow do-
*Correspondence: xur@cshl.edumain (CSD) at the C terminus (Aasland and Stewart,
1995; Eissenberg, 2001; Paro and Hogness, 1991). The
chromo domain of HP1 specifically recognizes the N-ter-
minal tail of histone H3 methylated at lysine-9, which pro-
vides a structural basis in support of the ‘‘histone code’’
hypothesis (Bannister et al., 2001; Jacobs and Khorasa-
nizadeh, 2002; Jenuwein and Allis, 2001; Lachner et al.,
2001; Nielsen et al., 2002). The CSD is responsible for
HP1 homodimerization and interaction with a number
of nonhistone nuclear proteins (Brasher et al., 2000;
Cowieson et al., 2000; Li et al., 2002; Ye et al., 1997). It
has been demonstrated that the HP1 CSD and the hinge
region are important for targeting HP1 proteins to spe-
cific genomic loci (Smothers and Henikoff, 2001).
Various proteins important for chromatin structure
and gene transcription have been found to interact
with the HP1 CSD (Lechner et al., 2005; Li et al., 2002).
They include the large subunit of chromatin assembly
factor-1 (CAF-1) (Brasher et al., 2000; Lechner et al.,
2000; Murzina et al., 1999) and components of the cellu-
lar transcriptional machinery (Vassallo and Tanese,
2002). In addition, the largest subunit of the origin recog-
nition complex (Orc1) interacts with full-length HP1
rather than with individual domains (Lidonnici et al.,
2004; Pak et al., 1997). In the budding yeast Saccharo-
myces cerevisiae, the interaction between the silencer
bound Orc1 with silencing information regulator-1 (Sir1)
is important for the establishment of the silenced chro-
matin domain at the cryptic mating-type loci (Gardner
et al., 1999; Triolo and Sternglanz, 1996; Zhang et al.,
2002). In higher eukaryotes, the interaction between
Orc1 and HP1 is likely to play an analogous role in the
formation of heterochromatin (Shareef et al., 2003).
A recent addition to the list of HP1-interacting pro-
teins is EMSY, which was identified as a protein that in-
teracts with the exon 3-encoded transcriptional activa-
tion domain of breast cancer susceptibility gene 2
(BRCA2) (Hughes-Davies et al., 2003). EMSY has been
implicated in BRCA2-associated sporadic breast and
ovarian cancer, but an understanding of its cellular func-
tions is lacking. EMSY is a large protein containing an
N-terminal domain (ENT) found in many plant proteins,
and the ENT domain is followed by an amino acid se-
quence involved in binding HP1 and BS69, the latter of
which was initially isolated as an adenoviral E1A binding
protein that recognizes the PXLXP sequence motif (An-
sieau and Leutz, 2002; Hateboer et al., 1995; Hughes-
Davies et al., 2003).
The EMSY sequence implicated in HP1 binding,
RLVPL, deviates from the consensus HP1 binding se-
quence PXVXL (positions 22 to +2) at the 22 position
(Smothers and Henikoff, 2000; Thiru et al., 2004). In the
structure of the HP1 CSD-CAF-1 peptide complex, the
proline at position 22 occupies a shallow hydrophobic
pocket (Thiru et al., 2004) that an arginine would not be
able to bind. To determine the exact mode of interaction
between the HP1 CSD and EMSY, we solved a 1.8 A˚ res-
olution cocrystal structure of the HP1b CSD in complex
with an N-terminal EMSY fragment encompassing the
ENT domain and the HP1/BS69 binding sites (EMSY-N,
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(A) A section of the MAD-phased electron density map surrounding the ENT-proximal HP1 binding site. The 2.3 A˚ map is shown in a filled chicken-
wire representation and is contoured at the 1.0s level. The refined model of the EMSY-HP1 CSD complex (stick model) is superimposed onto the
map. EMSY, HP1 CSD-A1, and HP1 CSD-A2 molecules are shown with carbon bonds colored yellow, magenta, and red, respectively.
(B) The overall structure of the EMSY-HP1 CSD complex shown in a ribbon representation. One asymmetric unit contains half of the EMSY ho-
modimer, and the other half (shaded) is related by a 2-fold symmetry. EMSY is colored yellow, the ENT-proximal CSD dimer (CSD-A) is shown in
magenta (CSD-A1) and red (CSD-A2), and the ENT-distal dimer (CSD-B) is shown in green (CSD-B1) and cyan (CSD-B2).
(C) Superposition of the backbones of CSD-A (red), CSD-B (green), and the HP1 CSD dimer of the HP1-CAF-1 complex (white).aa 9–139). The structure reveals an unexpected binding
mode for HP1 CSD to EMSY, which broadens our under-
standing of HP1 binding specificity, and the structural
information should be useful for identifying new HP1
binding proteins.
Results
Overall Structure
The structure was solved by the method of multiwave-
length anomalous dispersion (MAD) by using data col-
lected from a crystal with seleno-methionine (SeMet)-
substituted HP1 CSD. The high-quality MAD-phased
electron density allows for unambiguous tracing of
main chains and assignment of amino acids side chains
(Figure 1A). The modeled EMSY-N and the HP1 CSD
complex contains two HP1 CSD homodimers (aa 109–
175) bound to one EMSY-N (aa 9–124) in the asymmetric
unit (Figure 1B). The 1.8 A˚ refined model has excellent
stereochemical quality: 90.3% of the residues are in
the most-favored region of the Ramachandran plot,
and none are in the disallowed region, assessed by the
PROCHECK program (Laskowski et al., 1993). Detailed
statistics of structure determination and refinement are
shown in Table 1.
The ordered EMSY-N structure contains the ENT do-
main (aa 9–97) and a C-terminal extension containingthe HP1 binding sites (aa 98–124). The structure of the
ENT domain has been previously described (Chavali
et al., 2005). It consists mainly of five a helices: a1 and
a2 are antiparallel to each other, a3 and a5 are packed
on the same side of a1 and a2, and a4 contacts the
C-terminal end of a1 (Figure 1B). As noted in the work
of Chavali et al. (2005), the ENT domain forms a homo-
dimer, and the two ENT monomers are related by a
2-fold crystallographic symmetry in our structure (Fig-
ure 1B). Helices a1, a2, and a4 are engaged in extensive
dimeric interactions. The dimeric interface buries a total
ofw2976 A˚2 of pairwise solvent-accessible area, calcu-
lated with a probe radius of 1.4 A˚. The C-terminal exten-
sion of EMSY-N, which harbors the HP1 binding sites,
projects away from the dimeric interface (Figure 1B).
The HP1 CSD has a mixed a/b structure (Brasher et al.,
2000; Cowieson et al., 2000): three b strands (b1–b3) at
the N-terminal end form an antiparallel sheet, which is
stabilized by the packing of two approximately perpen-
dicularly oriented a helices (aA and aB) on one side of
the b sheet. The two helices are responsible for homo-
dimer formation, and they interact with the same helices
of another CSD monomer (Figure 1B). The two HP1 CSD
homodimers in the structure, denoted CSD-A and CSD-
B, have very similar monomeric structures. In addition,
the two monomers use similar modes to pack against
each other. The two homodimers can be superimposed
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705Table 1. Summary of Crystallographic Analysis
Data Sets Native Se (Inflection) Se (Peak) Se (Remote)
Resolution (A˚) 1.8 2.21 2.25 2.25
Measured reflections 303,912 219,016 210,023 213,824
Unique reflections 55,874 58,473 55,243 55,747
Average I/s 15.8 22.0 21.8 20.4
Completeness (%) 97.0 (96.0) 98.7 (100) 98.5 (100) 99.0 (100)
Rmerge (%)
a 5.2 (22.0) 5.8 (9.6) 6.3 (8.8) 6.4 (10.3)
Phasing powerb 2.41 2.65 1.84
Figure of merit 0.71 (total) 0.43 0.43 0.33
Refinement
Resolution range (A˚) 50–1.8
R factor/Rfree (%)
c 21.9/24.3
Protein atoms (number) 3,059
Solvent molecules
Water 386
Sulfate 4
Rms deviations
Bond lengths (A˚) 0.004
Bond angles (º) 1.197
a Rmerge =SjI2<I>j/S<I>, where I and <I> are the averaged intensity of multiple measurements of the same reflection. The summation is over all of
the observed reflections.
b Phasing power = rms (<FH>/E), where FH is the calculated structure factor of the heavy atoms, and E is the residual lack of closure.
c R factor =SkFoj2 jFck/S jFoj, where Fo denotes the observed structure factor amplitude, and Fc denotes the structure factor calculated from the
model.with a root-mean-square (rms) deviation of 0.56 A˚, using
the a/b core residues (aa 118–168) from both monomers
for alignment (Figure 1C). Using the same set of Ca
atoms, the NMR structure of the HP1b CSD (PDB ID:
1S4Z) (Thiru et al., 2004) dimer superimposes with
CSD-A, which is the homodimer bound to the ENT-prox-
imal site, with an rms deviation of 2.2 A˚ (Figure 1C).
Principal differences lie at the loops connecting b1-b2
and b2-b3, as well as at both the N and C termini
(Figure 1C). The conformational differences are likely
due to their involvement in protein-protein interactions
with EMSY or with the other HP1 dimer, which will be de-
scribed in detail below. Analogous to the binding of the
CAF-1 peptide (Thiru et al., 2004), the C-terminal end of
EMSY binds HP1 CSD homodimers mainly through the
C-terminal tails of the HP1 CSD.
HP1 Binding to the ENT-Proximal Site
The first HP1 CSD homodimer, CSD-A, binds to a region
adjacent to the helical ENT domain, and it also makes
a number of direct contacts with the globular ENT do-
main. The two monomers of CSD-A, termed CSD-A1
and CSD-A2, bind to EMSY asymmetrically: CSD-A1 is
closer to the ENT domain, while CSD-A2 is farther away
(Figure 1B). The CSD-A homodimer interacts mainly with
a consecutive stretch of EMSY residues (aa 97–106)
C-terminal to the ENT domain, which is in an extended
conformation and sandwiched between the C termini
of two CSD monomers. CSD-A also contacts the ENT
domain directly: CSD-A1 interacts with the globular
ENT domain through residues located on the b sheet,
and CSD-A2 contacts the ENT domain via its C terminus
(Figure 1B).
Residues 98–102 of EMSY, with the sequence of Arg-
Leu-Val-Pro-Leu, form an antiparallel intermolecular
b sheet pairing with residues 167–171 of CSD-A2. The
EMSY residues 101–104 form a parallel intermolecular
paring with residues 168–171 of CSD-A1 (Figure 1B).Pro101 of EMSY occupies a central position within the
symmetric CSD-A homodimer, and its side chain is situ-
ated in a symmetric hydrophobic pocket formed by
Tyr164 and Leu168 of both HP1 CSD monomers (Figures
2A and 2B). We call this binding site position 0, following
the nomenclature used in the description of the HP1b
CSD-CAF-1 peptide complex structure, in which a valine
occupies the corresponding site (Thiru et al., 2004). As in
the structure with the bound CAF-1 peptide, positions
22 and +2 are additional major interacting sites between
the HP1 CSD and EMSY (Figure 2B). Leu99 of EMSY
binds at the 22 position, which is formed with Leu168
and Trp170 of CSD-A2 and Ala125, Leu132, and Asp127
of CSD-A1 (Figure 2A). In addition, the main chains of
Thr169 of CSD-A2 and Thr126 of CSD-A1 form part of
the binding pocket. Met103 of EMSY occupies the +2
site, which is formed with Leu168 and Trp170 of CSD-
A1 and Ala125, Phe163, and Arg167 of CSD-A2 (Fig-
ure 2A). The composition of the 22 and +2 positions
clearly indicates the asymmetry of the two binding sites.
The main chain atoms of the EMSY residues at posi-
tions 21, +1, 23, and +3 are involved in intermolecular
b pairing with both molecules of CSD-A, but their side
chains point away from the center of the CSD dimer
and are only involved in mostly van der Waals contacts
with the CSD homodimer (Figures 2A and 2B). Of note
is the binding of EMSY Arg98 at position 23. It is sand-
wiched between Arg167 of CSD-A1 and Tyr173 of CSD-
A2 (Figure 2A). The small size of Pro104 at the +3 posi-
tion is probably needed to accommodate the binding
of a second CSD dimer, CSD-B, at the distal site. Arg105
of EMSY is at the +4 position; the aliphatic portion of the
side chain packs against Trp170 of CSD-A1, and its N3
atom makes a hydrogen bond with the Od1 atom of
Asp127 from CSD-A2 (Figure 2A). Finally, Leu106 of
EMSY at position +5 contacts Thr126, Leu135, and
Leu146, all from CSD-A2, through hydrophobic interac-
tions.
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(A) The binding of CSD-A to the ENT-proximal
site. The main chain of the ENT-proximal se-
quence is shown as a coil, and CSD-A is
shown in a ribbon representation (with the
C-terminal short b strands in coils for viewing
clarity). The residues involved in interactions
between EMSY and CSD-A are shown in stick
models; the same coloring scheme as that in
Figure 1 is used.
(B) The CSD-A homodimer is shown in a sur-
face representation, and the ENT-proximal
sequence is shown in a stick model. The
binding positions are labeled.
(C) Interactions between the CSD-A homo-
dimer and the globular ENT domain. Hydro-
gen bonds are indicated with dashed lines.CSD-A makes limited contacts with the globular ENT
domain through the C terminus of CSD-A2 and b sheet
residues of CSD-A1 (Figure 1B). Tyr173 of CSD-A2
makes van der Waals contacts with Arg68, Val71, and
Asn72 and hydrogen bonds to Od1 of Asn72, all located
on a3 of the ENT domain (Figure 2C). In addition, the
main chain atoms of Tyr173 and Pro174 of CSD-A2
make hydrogen bonds with the main chain and side
chain oxygen atoms of Ser93, located in a5 of EMSY.
The b sheet surface of CSD-A1 is close to the ENT do-
main surface region formed by the N-terminal ends of
helices a1 and a3. Glu143 located in the b2-b3 turn of
CSD-A1 hydrogen bonds with Arg21 in a1 and Arg62 in
a3 of the ENT domain (Figure 2C). Leu135 in b2 of
CSD-A1 makes van der Waals contacts with Glu61 and
Arg62 in a3 of the ENT domain. Furthermore, the car-
bonyl of Ile123 in b2 hydrogen bonds with Arg68 in a3,
and Thr126 makes van der Waals contacts with Glu61,
also in a3 of the ENT domain. These contacts appear
to augment the binding of CSD-A to the previously de-
scribed ENT-proximal site.
HP1 Binding to the ENT-Distal Site
The second HP1 CSD homodimer, CSD-B, interacts with
residues 106–124 of EMSY (Figures 1B and 3). Because
of the close juxtaposition of the two HP1 CSD homo-
dimers, Leu106 and Thr110 of EMSY interact with both
CSD-A and CSD-B: Leu106 of EMSY binds in a pocketformed by Thr126, Leu135, and Leu146 of CSD-A2 and
Tyr173 of CSD-B2, while Thr110 contacts Tyr173 of
CSD-A1 and Thr126 of CSD-B1 (Figure 4B).
As in the ENT-proximal HP1 binding site, EMSY resi-
dues at positions 23 to +1 (aa 111–115) are involved in
antiparallel intermolecular b pairing with residues 168–
171 of CSD-B2. EMSY residues at positions 0 to +2
form a parallel intermolecular b pairing with residues
169–171 of CSD-B1 (Figure 1B). Val114 of EMSY binds
in the hydrophobic pocket at position 0 of CSD-B, in
a manner similar to the binding of Pro101 of EMSY at
the corresponding CSD-A location (Figure 3). Phe112
of EMSY at position 22 interacts extensively with resi-
dues forming the 22 binding site of CSD-B, which con-
sist of CSD-B1 residues Ala125, Phe163, Tyr164, and
the aliphatic portion of Arg167, and CSD-B2 residues
Leu168 and Trp170 (Figure 3A). Instead of a bulkier ali-
phatic residue or methionine, as in the ENT-proximal
site and HP1 binding sequences in previous studies,
an alanine, Ala116, of EMSY occupies position +2 of
the ENT-distal site. The threonines at the21 and +1 po-
sitions of EMSY, Thr113, and Thr115 are engaged in sim-
ilar interactions with CSD-B: contacting Thr169 of both
CSDs and His171 of one of the molecules in the CSD-
B homodimer (Figure 3A). Ala118 of EMSY at the +4 po-
sition interacts with Trp170 and Pro174 of CSD-B1 and
Thr126 of CSD-B2 through van der Waals contacts,
while EMSY C-terminal residues Val119 and Val124
Structure of the HP1-EMSY Complex
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(A) The binding of the CSD-B dimer to the ENT-distal site. The residues involved in the interactions are shown in a stick model.
(B) A surface representation showing the binding of CSD-B to the ENT-distal sequence, which is shown in a stick model. The same coloring
scheme as that in Figure 1B (CSD-B1 in green, CSD-B2 in cyan, and EMSY in yellow) is used.exclusively interact with CSD-B2 residues located on
the b sheet surface, which include Thr126, Leu135,
Ala144, and Leu146 (Figure 3A).
HP1-HP1 Interactions
We noted earlier that the two CSD homodimers are in
close juxtaposition, and they interact with each other.
Extensive interactions are observed between CSD-A2
and CSD-B1, mainly between residues in the C-terminal
end of one protein and residues located at the N-termi-
nal end of b1 and the b2-b2 turn of another. Many of the
interactions are hydrogen bonds between the side
chains of charged residues in one CSD dimer and main
chain atoms of another CSD dimer. It is interesting to
note that the side chain-main chain hydrogen bonds be-
tween the two CSD proteins mimic a pattern of b sheet
hydrogen bonding (Figure 4A). The main chain-side
chain b sheet-type pairing occurs between two adjacent
CSD molecules, CSD-A2 and CSD-B1, belonging to two
different CSD homodimers. The interactions are approx-
imately symmetric, i.e., the charged side chains in CSD-
B1 make hydrogen bonds with main chain atoms of
C-terminal residues in CSD-A2, and, conversely, the
charged side chains in CSD-A2 make hydrogen bonds
with main chain atoms of C-terminal residues in CSD-
B1 (Figure 4A).
Additional interactions between the two CSD dimers
involve the packing of the C-terminal tail of CSD-A1
(aa 171–173) against the b sheet surface of CSD-B1
and the corresponding packing of the C-terminal tail of
CSD-B2 and the b sheet surface of CSD-A2. In particu-
lar, His171 of CSD-A1 makes a hydrogen bond withthe amide group of Ala144 of CSD-B1, and Tyr173 of
CSD-A1 binds in a position between Thr126 and
Leu135 and makes a hydrogen bond with the amide
group of Ala125 of CSD-B1 (Figure 4B). The correspond-
ing residues at the C-terminal end of CSD-B2 interact
with CSD-A2 differently, likely due to overlapping of
two HP1 binding sites in EMSY.
Comparison of HP1 CSD Bindings
Superposition of the ENT-proximal, ENT-distal, and
CAF-1 bound HP1 CSD dimers reveals that the three
CSD bound sequences are reasonably well aligned in
a region encompassing residues from positions 21 to
+5, with the largest deviation of Ca positions about 2.3
A˚. Larger deviations are observed for amino acids out-
side of this region, possibly due to their contacts with
the more flexible C-terminal ends of HP1 CSD (Fig-
ure 5A). Previous studies have revealed a HP1 CSD con-
sensus binding motif, PXVXL, where the proline at posi-
tion 22 and the valine at position 0 are crucial for HP1
binding (Smothers and Henikoff, 2000; Thiru et al.,
2004). The structural alignment reveals that the corre-
sponding residues are LVPLM and FTVTA at the ENT
proximal and distal sites, respectively (Figure 5A). In
particular, the proline at position22 is replaced by a leu-
cine in the ENT-proximal site and a phenylalanine in the
ENT-distal site, while the valine at position 0 can be
a proline.
An examination of the structure reveals that the pro-
line at position 0 binds in a manner similar to the valine
in the HP1-CAF-1 structure. Both residues are similar
in size, and they bind in the symmetric hydrophobic
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(A) An extensive network of side chain-main chain hydrogen bonds between CSD-A2 (red) and CSD-B1 (green) is shown; dashed lines indicate
the hydrogen bonds.
(B) Packing of the C-terminal residues of CSD-A1 (magenta) with CSD-B1 (green). Also shown are EMSY residues contacting both CSD dimers.
The same coloring scheme as that in Figure 1B is used.pocket of the HP1 CSD homodimer. The binding site for
the residue at position 22 appears to be more dynamic.
In the HP1-CAF-1 structure, the proline binds equidis-
tantly from Phe163 located on aB of one HP1 CSD
monomer and Trp170 at the C terminus of another
monomer. In the present structure, the C termini of the
HP1 CSD are farther away from helix 2, which results in
preferential packing of Leu99 in the proximal site and
Phe112 of the distal site with Trp170 (Figure 5A). This ob-
servation demonstrates that the position22 binding site
is capable of accommodating a variety of hydrophobic
residues, owing to the flexibility of the HP1 C terminus.
It was unexpected that two HP1 CSD homodimers
would be bound to one EMSY monomer. Because the
two homodimers contact each other and several EMSY
residues are contacted by both homodimers, we tested
whether the two HP1 CSD homodimers bind to EMSY in-
dependently. We generated two EMSY-N variants, one
lacking the second HP1 binding site (aa 9–110), termed
EMSY-N1, and another with the first binding sites (aa
97–109) removed, termed EMSY-N2. Figure 5B shows
that GST-fused HP1 CSD efficiently pulls down EMSY-
N1 (lane 9), but not EMSY-N2 (lane 11), which suggests
that the ENT-proximal site is an independent HP1 bind-
ing site, while the distal site is not. To determine whether
certain amino acids in the proximal region are required
for the binding of HP1 to the distal sites, we generated
a P101Q mutation in EMSY-N1 (lane 3) and EMSY-N
(lane 5), which changes the proline at position 0 to a glu-
tamine. As shown in Figure 5B, the P101Q mutant of
EMSY-N1 lost its ability to bind to HP1 CSD (lane 10); fur-
thermore, we cannot detect the binding of HP1 CSD tothe P101Q mutant of EMSY-N (lane 12), which has an
intact distal HP1 binding site. Conversely, if Val114 at
position 0 of the distal site is mutated to a glutamate
but the proximal site remains intact, the binding of the
HP1 CSD to EMSY-N is little affected (lane 13). Thus,
we conclude that the ENT proximal site is an indepen-
dent HP1 binding site but that the distal site is not.
To verify the 1:4 EMSY-N:HP1 CSD binding stoichiom-
etry, we performed a stable isotope mass spectrometry
quantitation experiment. HP1 was mixed with EMSY or
with EMSY-N1 (which can only bind one HP1 CSD ho-
modimer) in excess, and the resulting mixtures were
separated on a Superdex-200 gel filtration column to
isolate the complex from unbound components (Figures
6A and 6B). The HP1 CSD-EMSY-N (complex A) and HP1
CSD-EMSY-N1 (complex B) complexes were then dena-
tured and digested with trypsin. The complex A digest
was acetylated with acetic anhydride, while the complex
B peptides were acetylated with deuterated acetic anhy-
dride. This acetylation strategy results in a mass differ-
ence of 3 Da per incorporated acetyl group between
two identical peptides. The two digests were mixed to-
gether and analyzed by MALDI-TOF mass spectrometry.
The areas of three peptides coming from EMSY-N and
EMSY-N1 were used to normalize the amount of two
complexes (a representative spectrum is shown in Fig-
ure 6C), and the normalized ratios between the areas
of the same peptide bound to EMSY-N and EMSY-N1 re-
veal that EMSY-N binds approximately two times more
moles of HP1 than EMSY-N1 (2.1 6 0.1 averaged with
three different peptides). Thus, we conclude that the
1:4 EMSY-N:HP1 CSD stoichiometry observed in the
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(A) A stereodiagram showing the superposition of CSD-A (red), CSD-B (green), and the CSD dimer of the HP1-CAF-1 complex (white) bound to
their cognate binding sequences.
(B) Coomassie-stained gel showing the binding of the HP1 CSD to EMSY-N and its variants. Lanes 1–6, input samples of partially purified EMSY-N,
EMSY-N1, EMSY-N1(P101Q), EMSY-N2, EMSY-N(P101Q), and EMSY-N(V114E), respectively; lane 7, molecular weight marker; lanes 8–13, pro-
teins corresponding to those shown in lanes 1–6 bound to GSH resins preincubated with GST-HP1b CSD.
(C) Alignment of the HP1 binding sequences of EMSY orthologs. Shown from the top to the bottom are the sequences of human, mouse, zebra-
fish, Drosophila, and mosquito. The two binding sites are shown in bold face.crystal structure also represents a binding stoichiome-
try in solution.
Discussion
HP1 proteins play diverse roles in higher chromatin
structure and gene regulation, and their various interac-
tion partners have been described. The C-terminal CSD
is essential for most of the protein-protein interactions
studied to date. Previous structural and biochemical
studies have defined a short consensus HP1 CSD bind-
ing motif, PXVXL, which has greatly facilitated the un-
derstanding of the structural basis for HP1 binding
specificity (Smothers and Henikoff, 2000; Thiru et al.,
2004). This study reveals that the HP1 CSD has consid-
erable flexibility in accommodating the binding of differ-
ent amino acid sequences. Instead of the PXVXL motif,
the valine at position 0 can be a proline, and the proline
at position 22 can be a hydrophobic residue such as
a leucine or a phenylalanine. Thus, the HP1 binding motif
can be generalized to FX(V/P)X(L/M/V), where F stands
for hydrophobic residues. As shown earlier, we found
that the ENT-distal site is not capable of binding HP1
CSD independently. This is probably due to the pres-
ence of an alanine at position +2, which, in comparison
to the bulkier aliphatic residues or methionine, losesthe benefit of tighter interaction in the hydrophobic bind-
ing pocket. Our structural studies should facilitate the
identification of new HP1-interacting proteins and pro-
vide mechanistic insights into the broad role of HP1 pro-
tein-protein interactions.
A surprising finding of our study is that one EMSY
monomer binds to two HP1 CSD homodimers. In agree-
ment with previous binding studies, a shorter EMSY-N
fragment encompassing residues 1–108 binds one
HP1 CSD dimer, although the observed binding mode
in our crystal structure differs from that modeled ac-
cording to the structure of HP1 CSD in complex with
the CAF-1 peptide (Ekblad et al., 2005). Based on an un-
published observation, it has been suggested that a lon-
ger fragment of EMSY, encompassing residues 1–140,
which contains both HP1 binding sites observed in our
structure, also bind to HP1 CSD with same stoichiome-
try (Ekblad et al., 2005). The binding data are not neces-
sarily incompatible with our structural and mass spec-
trometry results. This is because, first, determination
of binding stoichiometry by isothermal titration calorim-
etry (ITC) requires the input of a binding model, which, in
the absence of the knowledge about the second binding
site, may lead to a different interpretation of the ITC re-
sults; second, our GST pull-down experiments demon-
strated that the second binding site does not function
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(A) A Superdex-200 column chromatogram showing the separation of the HP1 CSD-EMSY-N complex (complex A) from unbounded HP1 CSD.
The fraction used for mass spectrometry analysis is indicated with an arrow.
(B) Separation of the HP1 CSD-EMSY-N1 complex (complex B) from unbounded HP1 CSD on a Superdex-200 column. The arrow points to the
fraction used for mass spectrometry analysis.
(C) A representative spectrum of an acetylated EMSY peptide from EMSY-N (EMSY-A) and the same peptide from EMSY-N1 with a deuterated
acetyl group (EMSY-B). The sequence of the peptide is shown above the spectrum.
(D) A spectrum of a representative acetylated HP1 CSD peptide from the same complex A and complex B (deuterated) mixture as in (C). The
peptide sequence is indicated.independently, which suggests that, under certain con-
ditions, the EMSY-HP1 complex may exist as an equilib-
rium of subcomplexes in solution with the first or both
HP1 binding sites of EMSY occupied. It is possible
that interactions between HP1 CSD dimers stabilize
the binding of the second HP1 CSD dimer to the ENT-
distal site. An examination of EMSY orthologs from dif-
ferent species shows that both binding sites are highly
conserved, with the exception that the distal sites of
the Drosophila and mosquito proteins have an isoleu-
cine and a tyrosine at position 0, respectively (Figure 5C).
We do not know if HP1 can also bind to these two pro-
teins in a manner similar to what we observed here. It
is possible that the binding of a second HP1 homodimer
to EMSY is specific to certain species.
It is interesting that the close proximity of the two HP1
binding sites allows two adjacent CSD dimers to interact
with each other. To our knowledge, this represents the
first observation of interactions between HP1 CSD ho-
modimers. The structure shows that the two CSD
homodimers have good structural and chemical com-
plementarities, which suggests that, under favorable
conditions, HP1 CSD homodimers could form higher-
order structures. The result may be of great biological
interest because the HP1 dimer is known to spread
a long distance, yet no interaction between HP1 dimers
has been described. It is possible that interactions be-
tween HP1 homodimers in the vicinity of nucleosome
arrays can facilitate efficient polymerization and spread-ing of HP1, which is the hallmark of HP1 function in het-
erochromatin formation.
Experimental Procedures
Protein Purification and Crystallization
A cDNA fragment encoding residues 9–139 of EMSY (EMSY-N) was
cloned into a modified pGEX-KG vector bearing a PreScission pro-
tease (Amersham) cleavage site C-terminal to the GST tag. GST-
tagged EMSY-N was expressed by using the BL21(DE3) strain of
E. coli at 18ºC overnight. The GST fusion protein was first purified
on a glutathione-agarose (GSH, Sigma) column, followed by on-col-
umn digestion with the PreScission protease. The eluted protein was
further purified by gel-filtration column chromatography. Human
HP1b CSD (aa 104–175) was expressed as a poly(histidine)-tagged
protein by using the pET28a vector (Novagen). The his-tagged pro-
tein was first purified on a Ni-chelating column. After cleavage of the
His tag with thrombin, HP1bCSD was further purified by gel-filtration
column chromatography. To obtain the HP1b CSD-EMSY-N com-
plex, purified EMSY-N and HP1b CSD were mixed and incubated
on ice for 1 hr. To allow for efficient formation of the complex,
HP1b CSD was added in excess. The HP1b CSD-EMSY-N complex
was purified on a gel-filtration column (in a buffer containing 10
mM Tris [pH 8.0], 0.1 M NaCl, 1 mM DTT), which separated the com-
plex from the excessive HP1b CSD homodimer. The HP1b CSD-
EMSY-N complex was crystallized by using the hanging drop vapor
diffusion method at a protein concentration ofw20 mg/ml. The well
buffer contains 0.1 M Tris (pH 8.0) and 1.8 M ammonium sulfate.
Crystals grew over a period of 2–3 days, with typical dimensions
of 0.3 3 0.3 3 0.3 mm3. The crystal belongs to the P21212 space
group with cell dimensions of a = 143.4, b = 63.87, c = 66.64 A˚,
and it contains one EMSY-N and four HP1b CSD molecules per
asymmetric unit.
Structure of the HP1-EMSY Complex
711Data Collection and Structure Determination
X-ray diffraction data were collected at the X26C beamline of the Na-
tional Synchrotron Light Source (NSLS) at Brookhaven National Lab-
oratory (BNL). Both the native and seleno-methionine (SeMet)-
substituted crystals were flash frozen under a cold nitrogen stream
(100 K) during data collection. The data were processed by using the
HKL program suite (Otwinowski and Minor, 1997). Initial phases
were determined by using the SeMet multiwavelength anomalous
diffraction (MAD) data sets collected from a crystal of SeMet in
HP1b CSD. The SOLVE and CNS programs were used for location
of Se positions, phasing, and density modification (Brunger et al.,
1998; Terwilliger and Berendzen, 1999). The graphics program O
was used for model building (Jones et al., 1991), and refinement
was carried out by using CNS (Brunger et al., 1998). Phasing and re-
finement statistics are listed in Table 1. Figures were prepared with
PyMOL (DeLano, 2002).
Mutagenesis, GST Pull-Down, and Mass
Spectrometry Experiments
Deletion and amino acid substitution mutants of EMSY-N were gen-
erated by PCR, and the recombinant proteins were prepared in
a procedure similar to that described for the wild-type protein
used for crystallization. For pull-down experiments, GST-fused
HP1b CSD was expressed in E. coli. The lysate supernatant was in-
cubated with GSH resins for 30 min on ice, which was followed by
washing the resins with a buffer containing 20 mM Tris (pH 8.0),
0.5 M NaCl, 1 mM EDTA, 1 mM DTT, 0.02% NP-40, and 5% glycerol.
The washed resins were divided into several tubes, each containing
w20 mg proteins as determined by the Bradford assay. Approxi-
mately 50 mg purified EMSY-N or its variants were mixed with the
GST-HP1 CSD bound resins, and the mixture was incubated on
ice for 1 hr. The resins were then washed with the washing buffer de-
scribed above, except that the NaCl concentration had been re-
duced to 0.1 M. The proteins bound to the resins were then analyzed
by SDS-PAGE.
Gel-filtration fractions were supplemented with acetonitrile to 10%
and TCEP to 10 mM and were boiled for 5 min. Trypsin (20 ng)
was added to the cooled reaction and incubated at 37ºC for 12 hr.
The digested peptides were acetylated by the addition of 20 ml acetic
anhydride (complex A) or deuterated acetic anhydride (D6) (complex
B). The acetylation was allowed to proceed at room temperature for
1 hr and was then quenched by the addition of trifluoracetic acid to
0.5%. The two complexes were immediately mixed and desalted
by micro reverse-phase columns. The resulting mixture was mixed
with MALDI matrix (saturated trans-3-indole acrylic acid in 50% ace-
tonitrile, 0.1% acetic acid) and spotted directly onto the MALDI tar-
get. Mass spectra were collected by using an ABI 4700 and were
analyzed with Data Explorer (Applied Biosystems) and m/z (Genomic
Solutions) software programs. The relative stoichiometry was calcu-
lated by using the following formula: ([HP1A]/[HP1B])O ([EMSY-N]/
[EMSY-N1]), where the square bracket represents the area of a pep-
tide peak from the sample whose name is indicated inside the
bracket.
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